These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 22378260)

  • 1. An audience with Guido Rasi. Interview by Asher Mullard.
    Rasi G
    Nat Rev Drug Discov; 2012 Mar; 11(3):182. PubMed ID: 22378260
    [No Abstract]   [Full Text] [Related]  

  • 2. Richard Bergström. Interview by Asher Mullard.
    Bergström R
    Nat Rev Drug Discov; 2011 Jun; 10(6):408. PubMed ID: 21629284
    [No Abstract]   [Full Text] [Related]  

  • 3. David Haslam. Interview by Asher Mullard.
    Haslam D
    Nat Rev Drug Discov; 2013 Jul; 12(7):500. PubMed ID: 23764976
    [No Abstract]   [Full Text] [Related]  

  • 4. RuiPing Dong. Interview by Asher Mullard.
    Dong R
    Nat Rev Drug Discov; 2012 Feb; 11(2):100. PubMed ID: 22293559
    [No Abstract]   [Full Text] [Related]  

  • 5. Marc Kirschner. Interview by Asher Mullard.
    Kirschner M
    Nat Rev Drug Discov; 2011 Dec; 10(12):894. PubMed ID: 22129982
    [No Abstract]   [Full Text] [Related]  

  • 6. Mads Krogsgaard Thomsen. Interview by Asher Mullard.
    Thomsen MK
    Nat Rev Drug Discov; 2014 Feb; 13(2):96-7. PubMed ID: 24481301
    [No Abstract]   [Full Text] [Related]  

  • 7. Menelas Pangalos. Interview by Asher Mullard.
    Mullard A
    Nat Rev Drug Discov; 2013 Jun; 12(6):418. PubMed ID: 23722338
    [No Abstract]   [Full Text] [Related]  

  • 8. An audience with...Francis Collins. Interviewed by Asher Mullard.
    Collins F
    Nat Rev Drug Discov; 2011 Jan; 10(1):14. PubMed ID: 21151031
    [No Abstract]   [Full Text] [Related]  

  • 9. Mark Fishman. Interview by Asher Mullard.
    Fishman M
    Nat Rev Drug Discov; 2012 Jan; 11(1):14-5. PubMed ID: 22212670
    [No Abstract]   [Full Text] [Related]  

  • 10. An audience with... Susan Desmond-Hellmann. Interview by... Asher Mullard.
    Desmond-Hellmann S
    Nat Rev Drug Discov; 2011 Mar; 10(3):170. PubMed ID: 21358729
    [No Abstract]   [Full Text] [Related]  

  • 11. An audience with… Henry Chesbrough. Interview by Asher Mullard.
    Chesbrough H
    Nat Rev Drug Discov; 2013 May; 12(5):338-9. PubMed ID: 23598507
    [No Abstract]   [Full Text] [Related]  

  • 12. An audience with Thomas Lönngren. Interview by Asher Mullard.
    Lönngren T
    Nat Rev Drug Discov; 2010 Dec; 9(12):912. PubMed ID: 21119726
    [No Abstract]   [Full Text] [Related]  

  • 13. [Dismantling of "Big Pharma" gives new impetus to the pharmaceutical sector. Dynamic life science clusters can increase Swedish competitiveness].
    Hedner T; Gatenbeck L
    Lakartidningen; 2012 Jun 27-Jul 17; 109(26-28):1280-1. PubMed ID: 22852257
    [No Abstract]   [Full Text] [Related]  

  • 14. Trevor Mundel. Interview by Asher Mullard.
    Nat Rev Drug Discov; 2012 Mar; 11(4):264-5. PubMed ID: 22460116
    [No Abstract]   [Full Text] [Related]  

  • 15. Vertical disintegration: a strategy for pharmaceutical businesses in 2009?
    Dixon J; Lawton G; Machin P
    Nat Rev Drug Discov; 2009 Jun; 8(6):435. PubMed ID: 19483701
    [No Abstract]   [Full Text] [Related]  

  • 16. Michael Snyder. Interview by Asher Mullard.
    Snyder M
    Nat Rev Drug Discov; 2012 Oct; 11(10):744. PubMed ID: 23023673
    [No Abstract]   [Full Text] [Related]  

  • 17. Mark McClellan. Interview by Asher Mullard.
    McClellan M
    Nat Rev Drug Discov; 2012 Sep; 11(9):668. PubMed ID: 22935796
    [No Abstract]   [Full Text] [Related]  

  • 18. Open partnering of integrated drug discovery: continuing evolution of the pharmaceutical model.
    Hutchins S; Torphy T; Muller C
    Drug Discov Today; 2011 Apr; 16(7-8):281-3. PubMed ID: 21335101
    [No Abstract]   [Full Text] [Related]  

  • 19. An audience with... Tachi Yamada. Interviewed by Asher Mullard.
    Yamada T
    Nat Rev Drug Discov; 2013 Sep; 12(9):658-9. PubMed ID: 23989787
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug discovery management, small is still beautiful: Why a number of companies get it wrong.
    Knutsen LJ
    Drug Discov Today; 2011 Jun; 16(11-12):476-84. PubMed ID: 21504798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.